 | Up a level |
Number of items: 1.
Mallalieu, Navita L, Winter, Erica, Fettner, Scott, Patel, Katie, Zwanziger, Elke, Attley, Gemma, Rodriguez, Ignacio, Kano, Akiko, Salama, Sameeh M, Bentley, Darren et al (show 1 more authors)
(2020)
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers.
Antimicrobial agents and chemotherapy, 64 (5).
e02229-e02219.
